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Recent studies have suggested that the pan-B cell antigen CD20 (Bl, Bp35) plays
an important role in B cell activation . mAbs to CD20 induce different cellular re-
sponses depending on the antibody used and the stage of differentiation or activa-
tion of the target B cells. The mAb 1F5 activates resting B cells by initiating the
transition from the Go to the Gl phase ofthe cell cycle, and induces dense tonsillar
B cells to proliferate (1, 2). Other anti-CD20 mAbs such as Bl have been shown
to block B cell activation (3) and both 1F5 and Bl can inhibit B cell differentiation
(2). Recently it has been suggested that phosphorylation and internalization ofCD20
may be necessary steps for B cell entry into the Gl phase of the cell cycle (4, 5).
Here we report the isolation and expression of two CD20 cDNA clones using a re-
cently described technique (6).
Materials and Methods
BriefDefinitive Report
Preparation ofcDNA Library and Recovery ofcDNA Clones by Panning
￿
Poly(A)` RNA was pre-
paredfrom the human Burkitt cell line Daudi by oligo(dT) cellulose chromatography of total
RNA isolated by procedures described previously (6). cDNA preparation and expression li-
brary construction were carried out as described (6, 7).
Anti-CD20 mAbs 1F5, 2H7, Bl, L27, G28-2, 93-1B3, B-Cl, and NU-B2 were obtained
from the International Leukocyte Typing Workshop (4). Purified mAbs were used at a con-
centration of 1 ltg/ml and ascites were used at a dilution of 1 :1,000. Panning was done as
described (6) except that in the first round of screening, eight 10-cm dishes of 50% confluent
COS cells were transfected by the DEAE-Dextran method (7). Subsequent screening cycles
were performed by spheroplast fusion as described (6).
Immunoprecipitation, Sequencing RNA and DNA Blot Hybridization.
￿
The B cell line RAJI was
metabolically labeled with [35S]methionine and [35S]cysteine (200 ACi/ml) in cysteine/
methionine-free RPMI medium (Gibco Laboratories, Grand Island, NY) supplemented with
antibiotics and 5% dialyzed FCS for 12 h at 37'C. COS cells transfected by the DEAE-Dextran
method were similarly labeled 36 h posttransfection. The labeled cells were lysed with 1%
NP-40, 400 mM NaCl, 10 mM EDTA, and 10 mM ATP in PBS (8). After removing debris
and nuclei by centrifugation (13,000 g, 10 min), the lysate was precleared with protein A-agarose
beads (Calbiochem-Behring Corp., LaJolla, CA) and with nonspecific isotype-matched an-
tibody (mouse IgG2a, Coulter Immunology, Hialeah, FL) for 4 h. The resulting lysates were
incubated with Bl mAb (Coulter Immunology), 50 ltg/ml, at 4°C overnight. Fresh protein
A-agarose beadswere added for 1 h, washed five times with lysis buffer and eluted. The eluate
was electrophoresed through 12.5% polyacrylamide gels.
DNA and RNA blot analysis and hybridization probe preparation were carried out as de-
scribed previously (6, 7). Sequencing was done by the dideoxy method (6, 7).
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FIGURE 1 .
￿
Immunoprecipitation ofCD20 from (lane]) transfected COS
cells; (lane 2) Raji cell line ; (lane 3) Raji cells with nonspecific isotype-
matched antibody ; (lane 4) transfected COS cells with nonspecific iso-
type matched antibody. Molecular mass markers are shown to the left .
BCell Purification.
￿
Cells were gently teased from tonsils in sterilePBS. T cells were depleted
by anti-CD3/complement lysis; cells were incubated with CD3 mAb in PBS at 4°C for 45
min . After two washes in PBS, the cells were incubated with rabbit complement (Pel-freez
Biologicals, Rogers, AR) at 37°C for45 min . Monocytes were removed by two30-min rounds
of panning on tissue culture dishes at 37°C . 80-85% of the recovered cells were slgM' .
Results and Discussion
Two cDNA clones, bearing inserts of 1.5 (CD20 .4) and 1 .0 kb (CD20 .6), were
isolated from a Daudi cell cDNA library by panning with a panel ofmAbs against
CD20 . COS cells transfected with either clone reacted with all members of the panel
of antibodies . Immunoprecipitation of the cDNA-encoded protein from transfected
COS cells showed a single 33-kD band, slightly smaller than that obtained from
Raji cells (Fig . 1) .
The two cDNA inserts differed only in the 3' untranslated region . The insert in
clone CD20 .6 has a short poly(A) tail and lacks a consensus polyadenylation signal,
while the insert in CD20 .4 lacks a poly(A) tail and extends 431 by beyond the 3'
terminus in CD20.6 (Fig . 2 A) . While this manuscript was in revision, Einfeld et
al . (9) and Tedder et al . (10) have reported the isolation ofcDNA clones from phage
and plasmid libraries respectively.
RNA blot analysis showed that three transcripts of3 .8, 3 .0, and 1.5 kb were present
in B cells but absent from other cell types (Fig . 3), in agreement with the known
pattern of antibody reactivity (1, 2, 4, 5) . It appears likely that the CD20.6 clone
is derived from the 1.5-kb transcript or possibly from an even shorter, undetectable
species . Because the CD20 .4 clone lacks a poly(A)` tail, its source cannot be in-
ferred at present .
DNA blot analysis showed that the CD20 genomic sequences are not rearranged
during development and are not amplified in the cell lines examined . A restriction
fragment length polymorphism was observed in a DNA sample obtained from placenta
(Fig . 4) .
The amino acid sequence predicted by the cDNA contains 297 residues and has
a molecular mass of 33,097 daltons . The sequence contains three major hydrophobic
regions spanning residues 51-103, 117-141, and 183-203 (Fig . 1) . Two other notable
characteristics are the absence of an N112-terminal. signal peptide and the presence
of a highly chargedCOOH-terminal domain . A polyclonal anti-CD20 antibody that
recognizes the last 18 residues of the COOH terminus reacts with lysates of cells
expressing CD20 but not with intact cells (9), suggesting that the CD20 COOH
terminus is located within the cytoplasm . Since there is no NH2-terminal signalA
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1 AAAGACAAACTGCACCCACTGAACTCCGCAGCTAGCATCCAAATCAGCCCTTGAGATTTGAGGCCTTGGAGACTCAGGAGTTTTGAGAGC
91 AAAATGACAACACCCAGAAATTCAGTAAATGGGACTTTCCCGGCAGAGCCAATGAAAGGCCCTATTGCTATGCAATCTGGTCCAAAACCA
1 Met.Thr7hrProArgAsnSerValAsnGIyThrPhoProAluGIuProMetLysGIyProlleAlaMetGInSerGIyProLysPro
---CHO---
181 CTCTTCAGGAGGATGTCTTCACTGGTGGGCCCCACGCAAAGCTTCTTCATGAGGGAATCTAAGACTTTGGGGGCTGTCCAGATTATGAAT
30 LeuPheArgArgMetSerSerLeuVolGlyProThrGInSerPhePhoMetArgGIuSerLysThrLeuGIyAlaValGInIIoMetAsn
271 GGGCTCTTCCACATTGCCCTGGGGGGTCTTCTGATGATCCCAGCAGGGATCTATGCACCCATCTGTGTGACTGTGTGGTACCCTCTCTGG
B0 GIyLeuPhsHisIIoAleLeuGlyGiyLeuLeuMetIleProAiaGIyIlo7yrAloProIleCysValThrValTrpTyrProLeu7rp
361 GGAGGCATTATGTATATTATTTCCGGATCACTCCTGGCAGCAACGGAGAAAAACTCCAGGAAGTGTTTGGTCAAAGGAAAAATGATAATG
90 GIyGIyIleMetTyrlleIleSerGIySerLeuLeuAleAloThrGIuLysAsnSerArgLysCysLeuValLysGIyLysMetIleMet
451 AATTCATTGAGCCTCTTTGCTGCCATTTCTGGAATGATTCTTTCAATCATGGACATACTTAATATTAAAATTTCCCATTTTTTAAAAATG
120 AsnSerLeuSerLeuPheAlaAlaIleSerGIyMetIleLeuSerIIoMetA$PIIOLeuAsnIleLyslieSerMisPhoLeuLysMet
541 GAGAGTCTGAATTTTATTAGAGCTCACACACCATATATTAACATATACAACTGTGAACCAGCTAATCCCTCTGAGAAAAACTCCCCATCT
160 GI uSerLeuAsnPhoIleArgAlsHisThrProTyrIleAsnIleTyrAsnCysGIuProAlaAsnProSerGIuLysAsnSerProSer
631 ACCCAATACTGTTACAGCATACAATCTCTGTTCTTGGGCATTTTGTCAGTGATGCTGATCTTTGCCTTCTTCCAGGAACTTGTAATAGCT
180 ThrGInTyrCysTyrSerIleGInSerLeuPheLeuGIyIleLeuSerValMetLeullePh@Al&PhoPhoGInGIuLeuVaIIleAla
721 GGCATCGTTGAGAATGAATGGAAAAGAACGTGCTCCAGACCCAAATCTAACATAGTTCTCCTGTCAGCAGAAGAAAAAAAAGAACAGACT
210 GI ylleValGluAsnGIuTrpLysArgThrCysSerArgProLysSerAsnIleValLeuLeuSerAloGIuGIuLysLysGluGInThr
811 ATTGAAATAAAAGAAGAAGTGGTTGGGCTAACTGAAACATCTTCCCAACCAAAGAATGAAGAAGACATTGAAATTATTCCAATCCAAGAA
240 IIe GI uileLysGIuGIuValValGlyLeuThrGIuThrSerSerGInProLysAsnGIuGIuAspIleGIuIleIleProIleGInGlu
901 GAGGAAGAAGAAGAAACAGAGACGAACTTTCCAGAACCTCCCCAAGATCAGGAATCCTCACCAATAGAAAATGACAGCTCTCCTTAAGTG
270 GIuGluGIuGIuGIuThrGluThrAsnPheProGIuProProGInAspGInGIuSerSerProIleGIuAsnAspSerSerProEnd 297
---CHO---
99l ATTTCTTCTGTTTTCTGTTTCCTTTTTTAAACATTAGTGTTCATAGCTTCCAAGAGACATGCTGACTTTCATTTCTTGAGGTACTCTGCA
1081 CATACGCACCACATCTCTATCTGGCCTTTGCATGGAGTGACCATAGCTCCTTCTCTCTTACATTGAATGTAGAGAATGTAGCCATTGTAG
1171 CAGCTTGTGTTGTCACGCTTCTTCTTTTGAGCAACTTTCTTACACTGAAGAAAGGCAGAATGAGTGCTTCAGAATGTGATTTCCTACTAA
1261 CCTGTTCCTTGGATAGGCTTTTTAGTATAGTATTTTTTTTTGTCATTTTCTCCATCAGCAACCAGGGAGACTGCACCTGATGGAAAAGAT
1351 ATATGACTGCTTCATGACATTCCTAAACTATCTTTTTTTTATTCCACATCTACGTTTTTGGTGGAGTCCCTTTTTATCATCCTTAAAACA
1441 ATGATGCAAAAGGGCTTTAGAGCACAATGGATCT 1474
FIGURE 2 .
￿
(A) Sequence of the CD20.4 cDNA . The sites of potential N-linked glycosylation
are denoted by the symbol-CHO- ; the hydrophobic regions are underscored . The site of the
poly(A)' tail in clone CD20.6 is denoted by an asterisk . (B) Hydrophobicity profile of the amino
acid sequence in A .1978
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FIGURE 3 .
￿
RNA blot analysis . 20 wg of
total RNA were denatured, electropho-
resed through agarose, transferred to nylon
membranes, hybridized with CD20
cDNA, and exposed for 12 h . RNA sources
included the pre-B leukemia Nalm-6, the
B-LBL lines IM-9 andCESS the BL Raji,
the myeloma RPMI 8226, the T cell
leukemiajurkat, the myeloid lines HL60
and U937, tonsillar B cells (TBC),
lymphokine-activated T cells (TLA) and
peripheral blood T cells (TPBL).
peptide, it is likely that the NH2 terminus is also intracellular and that the first hy-
drophobic region acts as an internal membrane insertion signal . The first hydro-
phobic region is composed of 53 residues and is therefore long enough to span the
membrane twice if organized asana helix . Because there are two remaining hydro-
phobic regions, the intracellular localization of the COOH terminus requires that
the first hydrophobic domain exit the membrane on the intracellular side . Alterna-
tively, theCOON-terminal antibody mayonly recognize epitopes exposedby deter-
gent treatment allowing the COOH terminus to be extracellular and forcing the
first hydrophobic domain to exit the membrane on the extracellular side . The se-
quence contains two potential N-glycosylation sites (Asn-Xaa,Ser/Thr) at position
FIGURE 4 .
￿
DNA blot analysis. DNA samples were digested with Eco RI (a), Hind III (b), and
BamHI (c), electrophoresed through agarose, transferred to nylon, hybridized with CD20 cDNA,
and exposed for 48 h . DNA sources included placenta, the B-LBL lines LESS and JY and the
BL lines Raji and Namalwa . Molecular mass markers are shown for each blot.STAMENKOVIC AND SEED BRIEF DEFINITIVE REPORT
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9 and 293, but neither of these are expected to be used if they are located in intracel-
lular domains of the molecule. If the COOH terminus is intracellular, the only ex-
tracellular domain would lie between residues 142 and 182. This region is rich in
serine and threonine residues which might support 0-glycosylation.
Immunoprecipitation of transfected COS cells with the anti-CD20 mAb BI gave
a single 33-kD form (Fig. 2), suggesting that CD20 is not glycosylated in these cells.
In contrast, 35- and 37-kD species have been reported in certain B cell subsets and
lines (4, 5). It is possible that proteolysis, 0-linked glycosylation, or other posttrans-
lational modifications may account for the difference in mass. An alternative expla-
nation may be that alternate initiation sites are used in different B cell subpopula-
tions (9). The CD20 cDNA contains two NH2-terminal ATG codons separated by
16 residues. Neither ATG is embedded in the initiation consensus sequence pro-
posed by Kozak (11) . The use of the first or the second ATG would yield protein
molecular masses of 33 .1 and 30.8 kD, respectively. The immunoprecipitation result
shown in Fig. 2 suggests that only one ATG is used in both COS and Raji cells.
However, using a different immunoprecipitation protocol, we have detected a major
33-kD band and a minor 31-kD band in COS cells (data not shown). Further investi-
gation will be necessary to clarify these results.
Comparison ofthe peptide sequence with the sequences in the National Biomed-
ical Research Foundation database detected no significant homology to other pro-
teins by the FASTP rapid sequence alignment algorithm. Because the bulk of the
protein appears to be confined to the interior ofthe membrane and the cell, it seems
plausible that it may play a role in transducing signals from other transmembrane
proteins to the cell interior. Consistent with this role is the relatively hydrophilic
nature of the hydrophobic regions, which might allow hydrogen bond interactions
with the transmembrane portions of other proteins.
Summary
Two cDNA clones encoding the pan-B cell CD20 antigen were isolated from a
COS cell expression library. The two clones bear identical coding sequences and
differ only in the length ofthe 3' untranslated region. The predicted CD20 sequence
is 297 residues long and contains three hydrophobic domains, one of which is long
enough to span the membrane twice. COS cells transfected with either CD20 clone
express an immunoreactive protein of 33 kD.
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